Trial Profile
PS-SP PhaseIII Clinical Study; Investigation to find new formulation of mesalazine for treatment of patients with active Ulcerative Colitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 23 Oct 2013 New trial record
- 05 Jun 2013 Results published in Alimentary Pharmacology and Therapeutics.